211 related articles for article (PubMed ID: 29990496)
21. Allosteric regulation and substrate activation in cytosolic nucleotidase II from Legionella pneumophila.
Srinivasan B; Forouhar F; Shukla A; Sampangi C; Kulkarni S; Abashidze M; Seetharaman J; Lew S; Mao L; Acton TB; Xiao R; Everett JK; Montelione GT; Tong L; Balaram H
FEBS J; 2014 Mar; 281(6):1613-1628. PubMed ID: 24456211
[TBL] [Abstract][Full Text] [Related]
22. Aberrant splicing in B-cell acute lymphoblastic leukemia.
Black KL; Naqvi AS; Asnani M; Hayer KE; Yang SY; Gillespie E; Bagashev A; Pillai V; Tasian SK; Gazzara MR; Carroll M; Taylor D; Lynch KW; Barash Y; Thomas-Tikhonenko A
Nucleic Acids Res; 2018 Nov; 46(21):11357-11369. PubMed ID: 30357359
[TBL] [Abstract][Full Text] [Related]
23. NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup.
Elsaid MF; Ibrahim K; Chalhoub N; Elsotouhy A; El Mudehki N; Abdel Aleem A
BMC Med Genet; 2017 Mar; 18(1):33. PubMed ID: 28327087
[TBL] [Abstract][Full Text] [Related]
24. FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia.
Yu SL; Zhang H; Ho BC; Yu CH; Chang CC; Hsu YC; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Pui CH; Yang JJ; Zhang J; Lin DT; Lin SW; Ma X; Yang YL
Sci Rep; 2020 Jul; 10(1):12074. PubMed ID: 32694622
[TBL] [Abstract][Full Text] [Related]
25. Cytosolic 5'-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator.
Pesi R; Allegrini S; Balestri F; Garcia-Gil M; Cividini F; Colombaioni L; Jordheim LP; Camici M; Tozzi MG
Cells; 2021 Jan; 10(1):. PubMed ID: 33477638
[TBL] [Abstract][Full Text] [Related]
26. Genetic deletion of soluble 5'-nucleotidase II reduces body weight gain and insulin resistance induced by a high-fat diet.
Johanns M; Kviklyte S; Chuang SJ; Corbeels K; Jacobs R; Herinckx G; Vertommen D; Schakman O; Duparc T; Cani PD; Bouzin C; Andersén H; Bohlooly-Y M; Van der Schueren B; Oscarsson J; Rider MH
Mol Genet Metab; 2019 Apr; 126(4):377-387. PubMed ID: 30803894
[TBL] [Abstract][Full Text] [Related]
27. Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.
Lehmann-Che J; Bally C; Letouzé E; Berthier C; Yuan H; Jollivet F; Ades L; Cassinat B; Hirsch P; Pigneux A; Mozziconacci MJ; Kogan S; Fenaux P; de Thé H
Nat Commun; 2018 May; 9(1):2047. PubMed ID: 29795382
[TBL] [Abstract][Full Text] [Related]
28. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.
Evensen NA; Madhusoodhan PP; Meyer J; Saliba J; Chowdhury A; Araten DJ; Nersting J; Bhatla T; Vincent TL; Teachey D; Hunger SP; Yang J; Schmiegelow K; Carroll WL
Haematologica; 2018 May; 103(5):830-839. PubMed ID: 29449434
[TBL] [Abstract][Full Text] [Related]
29. Thiopurine Resistance in Childhood ALL Is Mediated by PRPS1 Mutations.
Cancer Discov; 2015 Jul; 5(7):693. PubMed ID: 25998402
[TBL] [Abstract][Full Text] [Related]
30. Schizophrenia risk proteins ZNF804A and NT5C2 interact in cortical neurons.
Aabdien A; Sichlinger L; Borgel Z; Jones MR; Waston IA; Gatford NJF; Raval P; Tanangonan L; Powell TR; Duarte RRR; Srivastava DP
Eur J Neurosci; 2024 Apr; 59(8):2102-2117. PubMed ID: 38279611
[TBL] [Abstract][Full Text] [Related]
31. Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment.
Brouwer C; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ; Bökkerink JP; Hoogerbrugge PM; van Wering ER; Veerman AJ; De Abreu RA
Clin Chim Acta; 2005 Nov; 361(1-2):95-103. PubMed ID: 15990089
[TBL] [Abstract][Full Text] [Related]
32. Thiopurine biology and pharmacology.
Aarbakke J; Janka-Schaub G; Elion GB
Trends Pharmacol Sci; 1997 Jan; 18(1):3-7. PubMed ID: 9114722
[No Abstract] [Full Text] [Related]
33. Leukemia Relapse-Associated Mutation of NT5C2 Gene is Rare in de Novo Acute Leukemias and Solid Tumors.
Oh HR; Choi YJ; Yoo NJ; Lee SH
Pathol Oncol Res; 2016 Jan; 22(1):223-4. PubMed ID: 26259531
[No Abstract] [Full Text] [Related]
34. Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.
Walldén K; Stenmark P; Nyman T; Flodin S; Gräslund S; Loppnau P; Bianchi V; Nordlund P
J Biol Chem; 2007 Jun; 282(24):17828-36. PubMed ID: 17405878
[TBL] [Abstract][Full Text] [Related]
35. Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemia.
Brouwer C; Keizer-Garritsen JJ; Lambooy LH; Ament K; Ter Riet PG; De Abreu RA; Bökkerink JP; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ; Trijbels JP
Adv Exp Med Biol; 2000; 486():327-31. PubMed ID: 11783509
[No Abstract] [Full Text] [Related]
36. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.
Ma X; Edmonson M; Yergeau D; Muzny DM; Hampton OA; Rusch M; Song G; Easton J; Harvey RC; Wheeler DA; Ma J; Doddapaneni H; Vadodaria B; Wu G; Nagahawatte P; Carroll WL; Chen IM; Gastier-Foster JM; Relling MV; Smith MA; Devidas M; Guidry Auvil JM; Downing JR; Loh ML; Willman CL; Gerhard DS; Mullighan CG; Hunger SP; Zhang J
Nat Commun; 2015 Mar; 6():6604. PubMed ID: 25790293
[TBL] [Abstract][Full Text] [Related]
37. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
38. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
Karas-Kuzelicki N; Mlinaric-Rascan I
Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
[TBL] [Abstract][Full Text] [Related]
39. What does over-expression of cN-II enzyme signify in haematological malignancies?
Galmarini CM
Leuk Res; 2007 Oct; 31(10):1325-6. PubMed ID: 17434583
[No Abstract] [Full Text] [Related]
40. Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.
Li B; Li H; Bai Y; Kirschner-Schwabe R; Yang JJ; Chen Y; Lu G; Tzoneva G; Ma X; Wu T; Li W; Lu H; Ding L; Liang H; Huang X; Yang M; Jin L; Kang H; Chen S; Du A; Shen S; Ding J; Chen H; Chen J; von Stackelberg A; Gu L; Zhang J; Ferrando A; Tang J; Wang S; Zhou BB
Nat Med; 2015 Jun; 21(6):563-71. PubMed ID: 25962120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
